In an era where data-driven insights guide nearly every facet of healthcare decision-making, continuing medical education (CME) has evolved beyond a professional obligation — it has become a measurable component of risk mitigation and organizational performance. For medical liability insurers and healthcare organizations alike, accredited education offers a structured mechanism to connect knowledge to behavior, resulting in safer, more defensible patient care.

Recognizing this potential, in 2022, the Integris Group, a Medical Professional Liability Insurance carrier, conducted an in-depth analysis of policy and claims data to determine whether CME participation correlates with improved professional liability outcomes. While education’s influence on clinical decision-making can be challenging to quantify, our study revealed compelling evidence that CME engagement is associated with reduced frequency in medical malpractice claims and improved financial stability across the insurance portfolio. Lower claims activity can indicate improved patient safety, adherence to best practices and less distraction from practicing medicine.

Study Design and Methodology

The study analyzed a sample of policies from 2018 and 2019 to identify observable differences between clinicians who participated in CME-accredited activities and those who did not. Due to the long life of a medical malpractice claim, which can range from 5-7 years, we used this sample of data. The dataset encompassed 4,766 policies, and of this dataset, 1,003 healthcare providers voluntarily participated in Integris-provided accredited education. Of these 1,003 providers, there were 437 closed claim files — a statistically meaningful foundation for comparison.

The study used a retrospective observational design by analyzing administrative insurance data including premiums, claims histories and educational participation records, for all insured individuals in the program. Educational engagement was quantified by activity completion and frequency and then categorized into low, moderate or high tiers. Outcomes included claims frequency and severity, adjusted for premium volume and historical risk. Stratified analyses by premium tier, prior claims activity and engagement level enabled comparison across similar risk groups, while multivariate models assessed whether educational participation was independently associated with reduced claims exposure.

Findings: Quantifying the Value of CME Participation

Among the policies reviewed, roughly $1 million in CME credit was awarded, equivalent to about 1.8% of total premium collected. While the relative cost of offering CME incentives appears modest, the corresponding difference in claims activity was striking.

Policies that included participation in accredited CME activities demonstrated a claims frequency of 6.75 claims per $1 million in premium, compared with 8.00 claims per $1 million for those without CME engagement. This represents a 15.6% relative reduction in claims frequency and a financially meaningful difference to Integris Group.

Although causation cannot be definitively established, this pattern reinforces the hypothesis that physicians engaging in accredited education are more likely to integrate risk-reducing behaviors into their clinical workflows. Education may not only refresh knowledge but also recalibrate decision-making, documentation and communication habits that influence liability exposure.

The findings align with prior research indicating that participation in accredited education contributes to improved adherence to evidence-based guidelines, enhanced patient outcomes and more effective team-based communication — all factors associated with lower malpractice risk (Levinson W, Roter D, Mullooly J, Dull V, Frankel R. Physician-patient communication: the relationship with malpractice claims among primary care physicians and surgeons. JAMA. 1997;277(7):553–559.).

Interpreting the Metrics: Beyond the Numbers

While the study did not attempt to measure specific behavioral changes resulting from participation in accredited education, the trends point toward a meaningful connection between structured learning and improved performance. The data suggest that even relatively small educational incentives can yield measurable benefits. Course discounts totaling less than 2% of premium resulted in a quantifiable decrease in claims activity — an impressive return on educational investment.

These insights have implications that extend well beyond financial metrics. CME serves as a mechanism for continuous professional growth, ensuring clinicians remain informed about evolving standards of care, regulatory expectations and emerging areas of liability. Educational initiatives focused on documentation, informed consent, communication and diagnostic accuracy are particularly valuable in preventing claim-generating errors.

In essence, CME can act as both a shield and a catalyst — a shield against preventable claims and a catalyst for sustained professional improvement. Integris Group sees this as a future area for additional study, perhaps measuring burnout rates in physicians with fewer claims, to further demonstrate the value of CME.

Strategic Implications for Medical Groups and Insurers

For medical professional liability carriers, the implications of our findings are significant. Integrating participation in accredited education into underwriting strategies, renewal incentives or premium credits can serve as a powerful tool to promote a culture of lifelong learning while simultaneously reducing exposure. From an actuarial standpoint, factoring educational engagement into predictive models may enhance accuracy in risk stratification and help insurers identify high-performing policyholders.

From the perspective of medical group practices and healthcare systems, encouraging physician participation in accredited CME — particularly those emphasizing risk management and patient safety — offers tangible operational advantages. Investing in CME supports credentialing and compliance efforts while reinforcing defensibility in the event of a malpractice claim. Additionally, it enhances organizational reputation by signaling a proactive commitment to quality and safety.

The broader organizational benefit lies in aligning CME with strategic objectives. When CME is designed not as a compliance task but as a performance driver, it strengthens the link between education, accountability and clinical excellence. For example, hosting an Antibiotic Stewardship education program can contribute to a culture in which learning and quality improvement become interdependent elements of risk management strategy.

Conclusion: Education as a Risk Management Strategy

The CME Metrics study reaffirms a fundamental truth that many in healthcare intuitively understand — education reduces risk. Though the measurable cost savings may appear incremental in isolation, their cumulative effect across an insurance portfolio is substantial. CME fosters a mindset of continuous improvement that influences how clinicians assess risk, document care, communicate with patients and apply judgments in complex scenarios.

As the healthcare landscape grows more complex — marked by shifting regulations, evolving technologies and increasing patient expectations — leveraging CME as both an educational and actuarial tool offers a unique opportunity. By aligning professional development with measurable outcomes, insurers and medical groups can transform CME from a regulatory checkbox into a strategic lever for performance and protection.

In the end, the message is clear — when clinicians learn, patients benefit and risks decline. Integrating CME into the fabric of organizational risk management is not just an investment in education, it’s an investment in sustainability, safety and integrity of healthcare delivery itself.

Disclosure: ChatGPT was used for creating heading titles.

Jordin Longo, CHCP, is a healthcare education leader who designs and delivers accredited learning programs that help physicians improve care quality, reduce risk, and stay compliant. As risk management CME specialist at Integris Group, she oversees education for more than 4,000 policyholders and leads initiatives that strengthen patient safety and organizational performance. Longo is known for combining data-driven strategy with creative program design to make learning meaningful and effective. She holds a degree in allied health sciences from the University of Connecticut and is a Certified Healthcare CPD Professional (CHCP).

Amy Zhang, FCAS, is a senior actuarial analyst specializing in pricing, reserving, reinsurance and financial reporting. She joined the Integris Group in Sept. 2022 and recently earned her fellow of the Casualty Actuarial Society (FCAS) designation. In her role, she focuses on delivering analytical insights and supporting strategic decisions that strengthen risk management and financial performance.